High dose of N-acetylcystein prevents acute kidney injury in chronic kidney disease patients undergoing myocardial revascularization

Annals of Thoracic Surgery

Volumn 97, Issue 5, 2014, Pages 1617-1623

  Santana Santos, Eduesley ^a   Gowdak, Luis Henrique W ^a   Gaiotto, Fabio A ^a   Puig, Luiz B ^a   Hajjar, Ludhmila A ^a   Zeferino, Suely P ^a   Drager, Luciano F ^a   Shimizu, Maria Heloisa M ^a   Bortolotto, Luiz A ^a   De Lima, Jose J G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; PLACEBO; SODIUM CHLORIDE; VASOACTIVE AGENT; VASODILATOR AGENT;

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DIURETIC THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; DYSLIPIDEMIA; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OXIDATIVE STRESS; POSTOPERATIVE HEMORRHAGE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION; SURGICAL PATIENT; SURGICAL RISK; TREATMENT OUTCOME;

ACETYLCYSTEINE; ACUTE KIDNEY INJURY; AGED; CARDIOPULMONARY BYPASS; CONFIDENCE INTERVALS; CORONARY ARTERY BYPASS; CORONARY STENOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HOSPITAL MORTALITY; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; PULSE THERAPY, DRUG; REFERENCE VALUES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84899921753     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2014.01.056     Document Type: Article

References (42)

1. G.M. Chertow, E.M. Levy, and K.E. Hammermeister et al. Independent association between acute renal failure and mortality following cardiac surgery Am J Med 104 1998 343 348
2. T.B. Ferguson, B.G. Hammill, E.D. Peterson for the Committee SND A decade of change - risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute Ann Thorac Surg 73 2002 480 490
3. R.H. Mehta, J.D. Grab, and S.M. O'Brien et al. Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery Circulation 114 2006 2208 2216
4. A. Lassnigg, D. Schmidlin, and M. Mouhieddine et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study J Am Soc Nephrol 15 2004 1597 1605
5. C.E. Hobson, S. Yavas, and M.S. Segal et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery Circulation 119 2009 2444 2453
6. R. Star, T. Hostetter, and G.L. Hortin New markers for kidney disease Clin Chem 48 2002 1375 1376
7. V.R. Dharnidharka, C. Kwon, and G. Stevens Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis Am J Kidney Dis 40 2002 221 226
8. I.Y. Tang, and P.T. Murray Prevention of perioperative acute renal failure: what works? Best Pract Res Clin Anaesthesiol 18 2004 91 111
9. R. Bellomo, S. Auriemma, and A. Fabbri et al. The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI) Int J Artif Organs 31 2008 166 178
10. M. Tepel, M. van der Giet, and C. Schwarzfeld et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine N Engl J Med 343 2000 180 184
11. F. Naughton, D. Wijeysundera, and K. Karkouti et al. N-acetylcysteine to reduce renal failure after cardiac surgery: a systematic review and meta-analysis Can J Anaesth 55 2008 827 835
12. S.U. Nigwekar, and P. Kandula N-acetylcysteine in cardiovascular-surgery- associated renal failure: a meta-analysis Ann Thorac Surg 87 2009 139 147
13. A.S. Adabag, A. Ishani, and H.E. Bloomfield et al. Efficacy of N-acetylcysteine in preventing renal injury after heart surgery: a systematic review of randomized trials Eur Heart J 30 2009 1910 1917
14. A. Ashworth, and S.T. Webb Does the prophylactic administration of N-acetylcysteine prevent acute kidney injury following cardiac surgery? Interact Cardiovasc Thorac Surg 11 2010 303 308
15. G. Wang, D. Bainbridge, and J. Martin et al. N-acetylcysteine in cardiac surgery: do the benefits outweigh the risks? A meta-analytic reappraisal J Cardiothorac Vasc Anesth 25 2011 268 275
16. U.M. Fischer, P. Tossios, and U. Mehlhorn Renal protection by radical scavenging in cardiac surgery patients Curr Med Res Opin 21 2005 1161 1164
17. R.L. Mehta, J.A. Kellum, and S.V. Shah et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury Crit Care 11 2007 R31
18. M. Joannidis, B. Metnitz, and P. Bauer et al. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database Intensive Care Med 35 2009 1692 1702
19. A.S. Levey, J.P. Bosch, and J.B. Lewis et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470
20. L.F. Prescott, J. Park, and A. Ballantyne et al. Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine Lancet 2 1977 432 434
21. P.I. Dargan, and A.L. Jones Acetaminophen poisoning: an update for the intensivist Crit Care 6 2002 108 110
22. I.A. Cotgreave N-acetylcysteine: pharmacological considerations and experimental and clinical applications Adv Pharmacol 38 1997 205 227
23. N. Sucu, I. Cinel, and A. Unlu et al. N-acetylcysteine for preventing pump-induced oxidoinflammatory response during cardiopulmonary bypass Surg Today 34 2004 237 242
24. S.A. Nashef, F. Roques, and P. Michel et al. European System For Cardiac Operative Risk Evaluation (EuroSCORE) Eur J Cardiothorac Surg 16 1999 9 13
25. W.A. Knaus, E.A. Draper, and D.P. Wagner et al. APACHE II: a severity of disease classification system Crit Care Med 13 1985 818 829
26. S.M. Gormley, W.T. McBride, and M.A. Armstrong et al. Plasma and urinary cytokine homeostasis and renal dysfunction during cardiac surgery Anesthesiology 93 2000 1210 1216 discussion 5A
27. P. Kiefer, J. Vogt, and P. Radermacher From mucolytic to antioxidant and liver protection: new aspects in the intensive care unit career of N-acetylcysteine Crit Care Med 28 2000 3935 3936
28. J. DiMari, J. Megyesi, and N. Udvarhelyi et al. N-acetyl cysteine ameliorates ischemic renal failure Am J Physiol 272 1997 F292 F298
29. J. Zhu, R. Yin, and H. Shao et al. N-acetylcysteine to ameliorate acute renal injury in a rat cardiopulmonary bypass model J Thorac Cardiovasc Surg 133 2007 696 703
30. K.E. Burns, M.W. Chu, and R.J. Novick et al. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing CABG surgery: a randomized controlled trial JAMA 294 2005 342 350
31. E. Sisillo, R. Ceriani, and F. Bortone et al. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial Crit Care Med 36 2008 81 86
32. E. Macedo, R. Abdulkader, and I. Castro et al. Lack of protection of N-acetylcysteine (NAC) in acute renal failure related to elective aortic aneurysm repair - a randomized controlled trial Nephrol Dial Transplant 21 2006 1863 1869
33. L.F. Drager, L. Andrade, and J.F. Barros de Toledo et al. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury Nephrol Dial Transplant 19 2004 1803 1807
34. I. El-Hamamsy, L.M. Stevens, and M. Carrier et al. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial J Thorac Cardiovasc Surg 133 2007 7 12
35. D.N. Wijeysundera, W.S. Beattie, and V. Rao et al. N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency Can J Anaesth 54 2007 872 881
36. E. Coll, A. Botey, and L. Alvarez et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment Am J Kidney Dis 36 2000 29 34
37. D. Fliser, and E. Ritz Serum cystatin C concentration as a marker of renal dysfunction in the elderly Am J Kidney Dis 37 2001 79 83
38. R. Bellomo, C. Ronco, J.A. Kellum for the Workgroup ADQI Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group Crit Care 8 2004 R204 R212
39. A. Ristikankare, T. Kuitunen, and A. Kuitunen et al. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery Br J Anaesth 97 2006 611 616
40. M.S. Hynninen, T.T. Niemi, and R. Pöyhiä et al. N-acetylcysteine for the prevention of kidney injury in abdominal aortic surgery: a randomized, double-blind, placebo-controlled trial Anesth Analg 102 2006 1638 1645
41. M. Haase, A. Haase-Fielitz, and S.M. Bagshaw et al. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients Crit Care Med 35 2007 1324 1331
42. Y. Abu-Omar, S. Mussa, and M.J. Naik et al. Evaluation of cystatin C as a marker of renal injury following on-pump and off-pump coronary surgery Eur J Cardiothorac Surg 27 2005 893 898